Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP13 | P45452 | 1/20 | 0.37 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TPMT | P51580 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12856118 | 1.00 | CA1 (0.37) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL1023387 | 0.97 | CA1 (0.35) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL1024671 | 0.97 | CA1 (0.35) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL1022384 | 0.97 | CA1 (0.35) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL1022571 | 0.97 | CA1 (0.35) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL9520705 | 0.80 | PDE10A (0.38) | ALDH1A1KDM4EMAPTTDP1 | |
| SCHEMBL9740926 | 0.80 | NMT1 (0.35) | ALDH1A1KDM4EMAPT | |
| SCHEMBL9739995 | 0.78 | NMT1 (0.34) | ALDH1A1KDM4E | |
| SCHEMBL16404373 | 0.78 | POLB (0.43) | ALDH1A1LMNATDP1HSD17B10 | |
| SCHEMBL6730284 | 0.75 | PGK1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 491 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117142916-B | Preparation method of allyl sulfone compound | 安徽金桐精细化学有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-117142916-A | Preparation method of allyl sulfone compound | 安徽金桐精细化学有限公司 | 2023-12-01 | — | — | CN | claimed |
| EP-2110392-B1 | DIVIDED REDOX-CURING-TYPE COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2020-05-06 | — | — | EP | claimed |
| US-8329845-B2 | Divided redox-curing type composition | KURARAY NORITAKE DENTAL INC. (JP) | 2012-12-11 | — | — | US | claimed |
| US-6984673-B2 | Dental cement composition | KURARAY CO., LTD. (JP) | 2006-01-10 | — | — | US | claimed |
| US-20260144714-A1 | KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | MITSUI CHEMICALS, INC. (JP) | 2026-05-28 | — | — | US | disclosed |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | KURARAY NORITAKE DENTAL INC. (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4725470-A1 | CURABLE DENTAL COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2026-04-15 | — | — | EP | disclosed |
| EP-3733152-B1 | POWDER-LIQUID TYPE RESIN-REINFORCED DENTAL GLASS IONOMER CEMENT COMPOSITION | SHOFU INC (JP) | 2026-03-11 | — | — | EP | disclosed |
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | SHOFU INC. (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4659729-A1 | DENTAL RESIN-REINFORCED GLASS IONOMER CEMENT COMPOSITION | Shofu Inc. (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-12478562-B2 | Dental restoration material composition | KURARAY NORITAKE DENTAL INC. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-6191191-B1 | USED AS BONDING AGENT, COMPOSITE RESIN, ADHESIVE AGENT, PRIMER AND OPAQUE PRIMER FOR DENTAL USE; LIGHT RESISTANCE; ADHESION TO TOOTH SURFACE AND METALS; COLORFASTNESS | KURARAY CO., LTD. (JP) | 2001-02-20 | — | — | US | disclosed |
| CN-1277834-A | Cementation composite and prepn. method therefor | KURARAY CO (JP) | 2000-12-27 | — | — | CN | disclosed |
| EP-1057468-A1 | Adhesive composition and method for producing it | KURARAY CO., LTD. (JP) | 2000-12-06 | — | — | EP | disclosed |
| CN-1273809-A | Binding compsns. | KURARAY CO (JP) | 2000-11-22 | — | — | CN | disclosed |
| EP-1051961-A1 | Bonding compositions for dental use | KURARAY CO., LTD. (JP) | 2000-11-15 | — | — | EP | disclosed |
| CN-1253767-A | Adhesive compound for tooth | KURARAY CO (JP) | 2000-05-24 | — | — | CN | disclosed |
| EP-0980682-A1 | Bonding compositions for dental use | KURARAY CO., LTD. (JP) | 2000-02-23 | — | — | EP | disclosed |
| EP-0948955-A1 | POLYMERIZABLE DENTAL COMPOSITION | KURARAY CO., LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060900-A1 | DENTAL COMPOSITE RESIN KIT | BOLA2; BOLA2B, LBR, COL2A1 | CA1 1024/4885CA2 959/4885MMP1 1019/4885 |
| US-20260144714-A1 | KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | CAD, KIT, ILK | CA1 291/4885CA2 1517/4885MMP1 1872/4885 |
| US-12478562-B2 | Dental restoration material composition | CAD, MAT2B, RER1 | CA1 1287/4885CA2 2513/4885MMP1 3906/4885 |
| US-12622847-B2 | Organosilicon compound and dental composition containing same | MSL1, ITGA1, ITGAL | CA1 166/4885CA2 473/4885MMP1 1950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.